Clinical Trials Browser

Phase EARLY_PHASE1 × Lymphoma, T-Cell × Clear all

Lymphoma, T-Cell, Epstein-Barr Virus Infections

NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05013372 2022-08-02

CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Phase EARLY_PHASE1 Unknown

12 enrolled

Lymphoid

Lymphoma, T-Cell

NCT05208853 2022-01-26

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Phase EARLY_PHASE1 Unknown

9 enrolled

Lymphoid

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

Phase EARLY_PHASE1 Terminated

1 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT02846935 2019-01-07

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

Phase EARLY_PHASE1 Completed

7 enrolled

Lymphoid

Lymphoma, T-Cell

NCT01878708 2017-03-06

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Phase EARLY_PHASE1 Terminated

2 enrolled

Lymphoid

Lymphoma, T-Cell

NCT00704691 2012-04-20

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

Phase EARLY_PHASE1 Terminated

1 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

GI-hNeoT-01

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas